Noted Researchers Laud Donation To Russian Science

George Soros, a Hungarian-born investor active in promoting free and open societies in Central and Eastern Europe through his philanthropy, has announced a $100 million donation to support scientific research in the countries of the former Soviet Union. His donation will establish an International Science Foundation for the Former Soviet Union. Although details about the foundation's staff and procedures remained sketchy when Soros announced the donation at the National Academy of Sciences in

Written byBilly Goodman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Although details about the foundation's staff and procedures remained sketchy when Soros announced the donation at the National Academy of Sciences in Washington, D.C., on December 9, he made it clear that he envisions a grant-making body loosely modeled on the United States' National Science Foundation. It would leapfrog the hierarchical structure of science that existed in the former Soviet Union, in which senior scientists got money to disburse to more junior colleagues. Instead, the new foundation plans to make grants to individual scientists based on merit.

"I very much hope the foundation will work to the transformation of what used to be Soviet science and make it science in the spirit of open society, which is my ideal," Soros said at a news conference announcing the donation.

"I believe only Western assistance can help the former Soviet Union from slipping into a black hole," Soros said.

Life for researchers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies